8.3 C
New York
Thursday, March 28, 2024

Dimon’s JPMorgan Stock Purchase Aims To Put Investors At Ease

Courtesy of Benzinga.

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that on July 16, 2012, the compensation committee of BioMarin’s board of directors approved the grant to two employees of stock options to purchase 13,400 shares of common stock in the aggregate and the grant of 1,310 restricted stock units to one of the employees.

The stock options and restricted stock units were granted pursuant to the BioMarin Pharmaceutical Inc. 2012 Inducement Plan, approved by the compensation committee of BioMarin’s board of directors on May 8, 2012 and as inducements material to the new employees entering into employment with BioMarin in accordance with NASDAQ Listing Rule 5635(c)(4).

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,453FansLike
396,312FollowersFollow
2,280SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x